2Krum H, Latini R, Maggioni AP, et al. Statins and symptomatic chronic systolic heart failure : a post-hoc analysis of 5010 patients enrolled in Val-HeF T. Int J Cardiol[ J] ,2007,119(1 ):48 -53. 被引量：1
3Talwar S, Downie PF, Ng LL, et al. Towards a blood test for heart failure: the potential use of circulating natriuretic peptides[ J]. Br J Clin Pharmacol,2000,50: 15 - 20. 被引量：1
4Cowie Mr. BNP: soon to become a routine measure in the care of patients with heart failure [ J ]. Heart, 2000,83 : 617 - 618. 被引量：1
5Harrison A, Morrison LK, Krishnaswamy P, et al. B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea[J]. Ann Emerg Med, 2002, 39:131 - 138. 被引量：1
6Senni M, Redfield MM. Heart failure with preserved systolic function : a different natural history [J]. J Am Coll Cardiol, 2001,38 : 1277 - 1282. 被引量：1
8Weber KT,Villarrel D.Aldosterone and antil dosterone therapy in congestive heart failure.Am J Cardiol,1993,71(3):3. 被引量：1
9Krum H,Latini R,et al.Statins and symptomatic chronic systolic heart failure:a post-hoc analysis of 5010 pationts enrolled in Val-HeF T[J].Int J Cardiol,2007,119(1):48-53. 被引量：1
10Gardner RS, Chong KS, Morton JJ, et al. A change in N-terminal- pro-brain natriuretic peptide is predictive of outcome in patients with advanced heart failure [ J]. Eur J Heart Fail,2007,9: 266 - 271. 被引量：1
